Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
October 13, 2019
Quantitative Analysis of Circulating Tumor Cells Using RNA-Based Digital Scoring
Mark Kalinich, Tanya T Kwan, Mehmet Toner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 13, 2026
Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® Study
Tanya T Kwan, Qingying Meng, Nathaniel Delos Santos, et al.
Cancer Discovery
|
August 15, 2018
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
Tanya T Kwan, Aditya Bardia, Laura M Spring, et al.
JAMA Oncology
|
October 14, 2021
Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib
Tanya T Kwan, Amit M Oza, Anna V Tinker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma
Mark Kalinich, Irun Bhan, Tanya T Kwan, et al.
Nature Communications
|
May 4, 2021
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Elizabeth M Swisher, Tanya T Kwan, Amit M Oza, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
October 13, 2019
Quantitative Analysis of Circulating Tumor Cells Using RNA-Based Digital Scoring
Mark Kalinich, Tanya T Kwan, Mehmet Toner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 13, 2026
Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® Study
Tanya T Kwan, Qingying Meng, Nathaniel Delos Santos, et al.
Cancer Discovery
|
August 15, 2018
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
Tanya T Kwan, Aditya Bardia, Laura M Spring, et al.
JAMA Oncology
|
October 14, 2021
Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib
Tanya T Kwan, Amit M Oza, Anna V Tinker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma
Mark Kalinich, Irun Bhan, Tanya T Kwan, et al.
Nature Communications
|
May 4, 2021
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Elizabeth M Swisher, Tanya T Kwan, Amit M Oza, et al.
Page
of 1